3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
6
INDUSTRY
1
Study Type
Observational
1
Sponsor
Conditions
Pain Related to Cancer
1
Opioid-Related Disorders
1
Lymphoma, Follicular
1
Cancer Pain
1
Interventions
Oxycodone
9
Fentanyl
6
Morphine
4
resiniferatoxin
3
nabiximols
3
Naloxone
2
Dronabinol
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
tanezumab
1
rofecoxib
1
naloxegol
1
fulranumab
1
cannabichromene
1
alvimopan
1
Venlafaxine Hydrochloride
1
Ultracet
1
Tapentadol
1
Standard of Care
1
Radiation
1
Propofol
1
Nerve Growth Factor
1
Methadone
1
Memantine
1
Inosine Monophosphate
1
Hydromorphone
1
Electroencephalography
1
Duration of Therapy
1
Cannabidiol
1
Antibodies
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Cancer Pain
×
Methadone
×
Clear all
NCT05265442
2024-10-31
DUNE
RECORDATI GROUP
Completed
136 enrolled